Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension

改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理

基本信息

  • 批准号:
    10630490
  • 负责人:
  • 金额:
    $ 4.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-15 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Resistant hypertension (RH) doubles the risk for adverse cardiovascular outcomes compared to non-resistant hypertension. Defined as having uncontrolled high blood pressure despite the use of at least 3 antihypertensive medications or controlled blood pressure on at least 4 medications, RH is estimated to affect at least 20 million Americans. Importantly, true RH must be differentiated from pseudo-resistant hypertension (pseudo-RH), occurring when blood pressure remains elevated due to extrinsic factors such as suboptimal medication dosing, medication non-adherence, or white-coat effect. Inability to distinguish true RH from pseudo-RH, and tailor treatment accordingly, compounds the risks of overtreating pseudo-RH (e.g. syncope, falls, acute kidney injury) as well as undertreating true RH (e.g. stroke, myocardial infarction). Distinguishing true from pseudo-RH, however, is clinically difficult, in part given the complexities involved in capturing medication adherence patterns and confirming white-coat effect. Therefore, our overall objective is to determine whether electronic health record (EHR) based analytics and tools can be used to close persistent gaps in care for RH. The specific aims of the research project are to: (1) develop and validate a computerized algorithm that uses EHR data to identify RH and distinguish between true and pseudo-RH including its subtypes; (2) develop and optimize a CDS tool for aiding clinicians in the identification and management of apparent RH; and, (3) pilot the implementation of a CDS tool for facilitating care of RH in addition to pseudo-RH and its subtypes. This research promises to enhance our understanding of how health information technology can be leveraged to inform scientific discovery, while also driving high-value care for RH. The proposed work will be conducted as part of a K23 award program, designed provide the advanced research skills and experience needed for the PI to successfully pursue an independent academic career focused on: (i) optimizing value of care (i.e. improved quality at decreased cost); (ii) leveraging health information technology and clinically generated data to gain new insights into disease states; and, (iii) promoting innovation in care delivery using implementation science principles. These efforts will be supported by the outstanding research environment and infrastructure of Cedars-Sinai including the Smidt Heart Institute, the Biostatistics and Bioinformatics Research Center, and the Research Informatics and Scientific Computing Core. Given the strong mentoring, institutional, and infrastructure supports in place, this award is ideally designed to provide the experience needed to launch the PI in his career as an independent investigator and future leader in cardiovascular outcomes research. This addended proposal includes plans for continuity of these research aims during a critical life event for the PI. This calls for the addition of new personnel who will assist with data validation, as well as coordination with external partners. The PI’s institution has provided flexibility for the clinical schedules for both the PI and new personnel to ensure success of this proposal. Further, this proposal outlines mechanisms by which the PI will replace missed training with equivalent opportunities.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Ebinger其他文献

Joseph Ebinger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Ebinger', 18)}}的其他基金

Behavioral Economics to improve Antihypertensive Therapy Adherence (BETA)
提高抗高血压治疗依从性的行为经济学(BETA)
  • 批准号:
    10399491
  • 财政年份:
    2021
  • 资助金额:
    $ 4.84万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10439510
  • 财政年份:
    2020
  • 资助金额:
    $ 4.84万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10216356
  • 财政年份:
    2020
  • 资助金额:
    $ 4.84万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10041734
  • 财政年份:
    2020
  • 资助金额:
    $ 4.84万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10653690
  • 财政年份:
    2020
  • 资助金额:
    $ 4.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了